HeartBeam, Inc.
BEATW Nasdaq Surgical & Medical Instruments & Apparatus Financials FY2020โFY2025
Last close ยท Oct 23, 2026
$0.01
22.6%What HeartBeam, Inc. does
No business description yet.
- Legal name
- HeartBeam, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K ยท Mar 12, 2026
- Accession ยท CIK
- 0001193125-26-104080
0001779372
Revenue and margins
HeartBeam, Inc. had โ of revenue in fiscal 2025.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was โ$14.6M in fiscal 2025, โ of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
HeartBeam, Inc. returned โ to shareholders in fiscal 2025. The diluted share count rose 26.5%.
Balance sheet
Cash, debt and the ratios that show how comfortably HeartBeam, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $13.2M | $3.6M | $16.2M | $2.4M | $4.4M |
| Interest coverage | โ1.1x | โ | โ | โ | โ |
| Current ratio | โ | โ | 14.1x | 1.7x | 1.4x |
| Quick ratio | โ | โ | 14.1x | 1.7x | 1.4x |
| Total assets | $14.0M | $4.0M | $17.1M | $3.3M | $5.8M |
| Total liabilities | $0.6M | $1.7M | $1.2M | $1.6M | $3.2M |
| Shareholders' equity | $13.4M | $2.4M | $15.9M | $1.7M | $2.6M |
| Net debt (โ = net cash) | โ | โ | โ | โ | โ |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ | โ |
| F-score | โ / 3 | โ / 5 | โ / 5 | โ / 5 | โ / 6 | โ / 6 |
| Accruals ratio | โ917.6% | โ17.1% | โ33.4% | โ24.1% | โ48.8% | โ154.1% |
| Altman Z'' | โ | โ | โ | 6.99 | โ93.42 | โ64.97 |
6 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Research and development | $0.1M | $0.3M | $5.7M | $6.8M | $11.1M | $13.5M |
| Operating income | โ$0.8M | โ$2.3M | โ$13.0M | โ$15.3M | โ$19.9M | โ$21.1M |
| Interest expense | $0.3M | $2.2M | โ | โ | โ | โ |
| Pretax income | โ$1.1M | โ$4.4M | โ$13.0M | โ$14.6M | โ$19.4M | โ$21.0M |
| Income tax | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net income | โ$1.1M | โ$4.4M | โ$13.0M | โ$14.6M | โ$19.4M | โ$21.0M |
| Diluted EPS | โ$0.29 | โ$1.03 | โ$1.59 | โ$0.72 | โ$0.73 | โ$0.62 |
| Diluted shares | 0.00B | 0.00B | 0.01B | 0.02B | 0.03B | 0.03B |
| Cash flow | ||||||
| Cash from operations | โ$0.6M | โ$3.2M | โ$9.9M | โ$12.1M | โ$14.5M | โ$14.0M |
| Capital expenditure | โ | โ | $0.0M | $0.3M | $0.2M | $0.6M |
| Free cash flow | โ | โ | โ$9.9M | โ$12.3M | โ$14.7M | โ$14.6M |
| Depreciation and amortization | โ | โ | โ | $0.0M | $0.0M | $0.0M |
| Stock-based compensation | $0.0M | $0.2M | $1.1M | $3.2M | $4.3M | $5.1M |
| Balance sheet | ||||||
| Cash and short-term investments | $0.0M | $13.2M | $3.6M | $16.2M | $2.4M | $4.4M |
| Current assets | โ | โ | $4.0M | $16.8M | $2.8M | $4.7M |
| Current liabilities | $4.8M | โ | โ | $1.2M | $1.6M | $3.2M |
| Inventory | โ | โ | โ | โ | $0.0M | $0.1M |
| Property and equipment, net | โ | โ | $0.0M | $0.3M | $0.5M | $1.1M |
| Total assets | $0.1M | $14.0M | $4.0M | $17.1M | $3.3M | $5.8M |
| Total liabilities | $4.8M | $0.6M | $1.7M | $1.2M | $1.6M | $3.2M |
| Preferred stock | โ | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | โ$4.8M | $13.4M | $2.4M | $15.9M | $1.7M | $2.6M |
| Returns | ||||||
| Return on capital employed | 16.5% | โ | โ | โ96.1% | โ1,202.4% | โ812.1% |
| Return on equity | โ | โ102.7% | โ164.2% | โ159.9% | โ221.1% | โ987.3% |
| Return on assets | โ2,094.1% | โ63.0% | โ143.7% | โ138.3% | โ190.6% | โ460.9% |
| Return on tangible equity | โ | โ33.0% | โ546.0% | โ91.9% | โ1,175.8% | โ807.3% |
| Growth | ||||||
| Share count change | โ | 17.5% | 90.6% | 148.9% | 31.0% | 26.5% |
| Financial health | ||||||
| Interest coverage | โ2.8x | โ1.1x | โ | โ | โ | โ |
| Current ratio | โ | โ | โ | 14.1x | 1.7x | 1.4x |
| Quick ratio | โ | โ | โ | 14.1x | 1.7x | 1.4x |
| Quality scores | ||||||
| Altman Z'' | โ | โ | โ | 7.0 | โ93.4 | โ65.0 |
| Accruals ratio | โ917.6% | โ17.1% | โ33.4% | โ24.1% | โ48.8% | โ154.1% |
Source: SEC EDGAR XBRL filings (CIK 0001779372). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only โ not investment advice. Check the original filings before relying on any figure.
